MAY 24, 2017 11:37 AM PDT

Modified malaria vaccine hopeful

WRITTEN BY: Kerry Evans

Malaria is caused by the protozoan parasite Plasmodium falciparum. The parasite enters red blood cells, eventually causing them to burst (and that’s never a good thing). The parasites are pretty clever when it comes to entering our cells. They secrete a receptor protein called rhoptry neck protein 2 (RON2) onto the surface of the red blood cell. Then, they express a surface protein called apical membrane antigen 1 (AMA1) that binds to the RON2L portion of RON2. Voila! The parasite is attached to the red blood cell!


New malaria vaccine targets host-cell attachment.


There are already some experimental vaccines for malaria that contain the AMA1 protein. These vaccines do produce an antibody response in humans, but they have not been very effective in field trials. In an effort to make a better malaria vaccine, NIAID researchers added RON2L to the vaccine, along with AMA1. Then, they tested the new vaccine in Aotus monkeys.


They randomized the monkeys into three groups - an adjuvant control, and AMA1 vaccine group, and an AMA1/RON2L vaccine group. The animals received three doses of their respective vaccines, and after four weeks, they were infected with P. falciparum.


As expected, all of the animals in the control group tested positive for P. falciparum and were treated for parasitemia. All of the animals vaccinated with AMA1 tested positive for P. falciparum, but only 50% of the animals vaccinated with AMA1/RON2L tested positive for the parasite!


Next, they investigated the vaccine-induced antibody response. The levels of AMA1-specific antibody were similar between the AMA1 vaccine and AMA1/RON2L vaccine groups. They hypothesized that the AMA1/RON2L vaccine may induce the production of better quality AMA-1 antibodies.


To test this, they used a growth-inhibition assay to measure the parasite-neutralizing activity of the antibodies. IgG that was purified from the AMA1/RON2L vaccine group neutralized more parasites than IgG from the AMA1-only group.


Next, they investigated whether antibodies that blocked the interaction between AMA1 and RON2L correlated with protection. As expected, the level of blocking antibodies was much higher in animals vaccinated with AMA1/RON2L.


Finally, they determined whether the AMA1/RON2L vaccine could protect animals from other strains of P. falciparum. Sure enough, IgG from animals that received the AMA1/RON2L vaccine neutralized 3D7 and GB4 strain parasites better than IgG from animals that received the AMA1 vaccine.


Sources: Nature and Science Daily


About the Author
  • Kerry received a doctorate in microbiology from the University of Arkansas for Medical Sciences.
You May Also Like
OCT 20, 2019
Health & Medicine
OCT 20, 2019
Increasing Incidence of Tick-Borne Illnesses in Pennsylvania
Babesiosis is a vector-borne disease in which the parasite, Babesia, is transmitted through the bite of a tick, or rarely, a blood transfusion.  ...
OCT 20, 2019
Genetics & Genomics
OCT 20, 2019
Does Viral DNA in the Human Genome Cause Disease?
Millions of years ago, retroviruses interacted with our primordial ancestors, and it's estimated that 8% of the human genome comes from viruses....
OCT 20, 2019
Earth & The Environment
OCT 20, 2019
How temperature affects citrus-greening disease
Ever heard of huanglongbing? While more commonly referred to as citrus greening disease, huanglongbing (HLB) is threatening your favorite morning beverage ...
OCT 20, 2019
OCT 20, 2019
Picturing a New Kind of Antibiotic
Scientists have deciphered the X-ray crystal structure of an enzyme that generates a unique broad spectrum antibiotic called obafluorin....
OCT 20, 2019
Cell & Molecular Biology
OCT 20, 2019
A Protein Sensor That Helps a Stomach Bug Find a Good Home
A bacterial pathogen called Helicobacter pylori is known to colonize the stomach and cause ulcers....
OCT 20, 2019
OCT 20, 2019
A Mosquito-borne Disease Called EEE is Spreading This Year
Massachusetts health officials confirmed yesterday that a third person has died from Eastern Equine Encephalitis this year....
Loading Comments...